| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Guiheen Lawrence P. | Director | C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY | /s/ Lawrence P. Guiheen, by Adam S. Grossman as Attorney-in-fact | 23 May 2025 | 0001554353 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADMA | Common Stock | Options Exercise | $46,363 | +7,779 | +6.8% | $5.96 | 122,609 | 21 May 2025 | Direct | |
| transaction | ADMA | Common Stock | Sale | $158,069 | -7,779 | -6.3% | $20.32 | 114,830 | 21 May 2025 | Direct | F1 |
| transaction | ADMA | Common Stock | Options Exercise | $7,277 | +1,221 | +1.1% | $5.96 | 116,051 | 22 May 2025 | Direct | |
| transaction | ADMA | Common Stock | Sale | $24,567 | -1,221 | -1.1% | $20.12 | 114,830 | 22 May 2025 | Direct | F2 |
| holding | ADMA | Common Stock | 50,990 | 21 May 2025 | See footnote | F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ADMA | Stock Option (right to buy) | Options Exercise | $0 | -7,779 | -86% | $0.000000 | 1,221 | 21 May 2025 | Common Stock | 7,779 | $5.96 | Direct | F5, F6 |
| transaction | ADMA | Stock Option (right to buy) | Options Exercise | $0 | -1,221 | -100% | $0.000000 | 0 | 22 May 2025 | Common Stock | 1,221 | $5.96 | Direct | F5, F6 |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.20 to $20.73. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. |
| F2 | Includes, as of the transaction date, (i) 10,889 restricted stock units granted on February 19, 2025, which vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of such vesting date; and (ii) 103,941 shares of common stock owned by the Reporting Person. The number of common shares reported includes a de minimis reduction by 10 shares from the amount previously reported due to a broker adjustment. |
| F3 | Includes 50,990 shares of common stock held in the Lawrence P Guiheen Irrevocable Trust 1 (the "Guiheen Irrevocable Trust"), of which 49,990 shares were inadvertently reported in prior reports as directly owned. |
| F4 | These shares are owned by the Guiheen Irrevocable Trust. |
| F5 | The Reporting Person is exercising this option due, in part, to its near-term expiration date. |
| F6 | These options were granted on January 28, 2016 and vested in twenty-four equal monthly installments, becoming fully vested on January 28, 2018. |